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Little information is known about the genetic mechanisms of the pathophysiology of varicose veins (VVs). The purpose 
of this study was to systematically explore the biological pathways of genes speculatively participating in VVs by 
microarray bioinformatics analysis methods. The results showed that 32 genes were upregulated and 74 genes were 
downregulated in VVs. Gene Ontology and relevant bioinformatics tools indicated that the functional categories in 
which 106 genes (2.8%; 106/3800) of the most frequent alteration belonged to were apoptosis and angiogenesis. The 
analysis of 20 VV tissue specimens demonstrated that genes involved in angiogenesis and apoptosis pathways had high 
rates of overexpression. In addition, we discovered that genes involved in the angiogenesis pathways included HSP90, 
ILK, and TGFB1, and they played key roles in the development of VVs. This study demonstrated that the angiogenesis 
and apoptosis pathways may play an important role in the formation of VVs, but their molecular mechanisms need 
further investigation.
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Introduction
More than 50% of people above 40 years of age suffer 
from varying degrees of varicose veins (VVs). VVs 
mostly affect females, and are related to prolonged 
standing, obesity, pregnant patients, and appear 
on the leg area. VVs are related to genetic and en-
docrine factors, and female hormones. Moreover, 
VVs not only affect patient cosmetic problems, but 
also cause pain, itching and pigmentation.1 From 
their appearance, VVs can be divided into six clinical 
grades; the higher the grade, the worse the condi-
tion. Although VVs are a common cause of morbidity, 
etiologic factors predisposing to dilatation, elon-
gation, and its tributaries are poorly understood.2−4 
Since there are potential differences for the devel-
opment of VVs among individuals, this study used 
microarray bioinformatics analysis methods to sys-
tematically explore the biological pathways of genes 
speculatively participating in VVs. Biological path-
ways related to VVs need to be fully understood, 
so that subjects who are at high risk for VVs might 
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be identified for early prevention and effectively 
reduced disease occurrence, thus improving their 
quality of life. Furthermore, this could help identify 
whether subjects are in the high-risk group of post-
operative recurrence owing to the molecular 
mechanism causing VVs. This information could im-
prove postoperative care as early as possible and 
preventive medicine.
Materials and Methods
Messenger RNA isolation and complementary 
DNA synthesis
Total RNA was extracted from VVs and control veins 
(CVs) of VV patients with Isogen (Nippon Gene, 
Toyama, Japan) by following the modified acid-
guanidine thiocyanate and phenol/chloroform extrac-
tion method.
Oligonucleotide microarray
The oligonucleotide array contains 3800 elements 
designed for expression profiling, for which over 3200 
well-characterized, full-length human genes were 
defined. First-strand complementary DNA targets 
for hybridization were made by reverse transcrip-
tion of the messenger RNA isolated from both the 
VVs and paired CVs from the same case by using 
SuperScript II RT (Gibco-BRL, Gaithersburg, MD, 
USA) in the presence of either Cy3- or Cy5-labeled 
deoxyuridine triphosphate (Amersham Pharmacia 
Biotech, Piscataway, NJ, USA).
Functional genomics analysis
Functional genomics analysis was performed ac-
cording to our recent study.5 A program package, 
MatchMiner (http://discover.nci.nih.gov/matchminer/
index.jsp), was briefly used to scan human genome 
Table Upregulated genes in varicose veins
GenBank number Gene name
NM_006098 Guanine nucleotide binding protein
NM_005965 Myosin, light polypeptide kinase (MYLK)
NM_005348 Heat shock 90 kD protein 1, (HSPCA) PRO0470 protein (PRO0470)/ferritin, light 
NM_002856 Poliovirus receptor-related (PRR2) protein
NM_002265 Karyopherin (importin) 1 (KPNB1)
NM_001614 Actin, 1 (ACTG1)
NM_003564 Transgelin 2 (TAGLN2)
NM_005572 Lamin A/C (LMNA)
NM_000088 Collagen, type I, alpha 1 (COL1A1)
NM_003186 Transgelin (TAGLN)
NM_006009 Tubulin, brain-specific (TUBA3)
NM_001102 Actinin, 1 (ACTN1)
NM_002444 Moesin (MSN)
NM_006082 Tubulin, ubiquitous (K-ALPHA-1)
NM_004517 Integrin-linked kinase (ILK)
NM_002345 Lumican (keratan sulfate proteoglycan)
NM_003289 Tropomyosin, skeletal muscle
NM_021019 MYL6 (myosin, light polypeptide 6)
NM_004719 Splicing factor, arginine/serine-rich 2-interacting protein 1; DEAD/H (Asp-Glu-Ala-Asp/His)
NM_004939 Box polypeptide 1
NM_002813 Proteasome (prosome, macropain) 26S subunit
NM_012423 Ribosomal protein L13a (RPL13A)
NM_007173 Protease, serine, 23 (SPUVE)
NM_004181 Ubiquitin carboxyl-terminal esterase L1
NM_001686 ATP synthase 
NM_002116 Major histocompatibility complex, class I, A (HLA-A)
NM_022310 Mus musculus heat shock 70 kD protein 5
NM_000358 Transforming growth factor, induced, 68 kD (TGFB1; BIGH3)
NM_003945 ATPase, H+ transporting, lysosomal (vacuolar proton pump)
NM_005469 Peroxisomal acyl-CoA thioesterase
NM_015994 Vacuolar proton pump delta polypeptide
NM_001219 Calumenin 
NM_032692 Phosphoglycerate dehydrogenase (PHGDH)
NM_002046 Glyceraldehyde-3-phosphate dehydrogenase
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organization (HUGO) names for significantly ex-
pressed genes (≥ twofold increase in intensity) 
initially screened by complementary DNA microar-
ray analysis. The HUGO names were then input 
into GoMiner (http://discover.nci.nih.gov/gominer), 
which leveraged the Gene Ontology to identify the 
biological pro cesses, functions and components 
represented in the gene profile. We also used the 
Database for Annotation, Visualization, and Inte-
grated Discovery (DAVID) (http://niaid.abcc.ncifcrf.
gov) and the Kyoto Encyclopedia of Genes and 
Genomes (KEGG) database (http://www.genome.
ad.jp/kegg).
Results
In our microarray data analysis results from three 
pairs of VVs, we used GeneSpring (GeneSpring GX 7; 
Agilent Technologies, Inc., Santa Clara, CA, USA) 
software to standardize data and transform data 
into images. After standardization, the microarray 
data were screened for the different gene expres-
sions in CV and VV tissues, and a total of 106 genes 
were selected. The gene bank accession number 
(HUGO names) of the 106 gene clusters, when differ-
entially expressed, were replaced with the bioinfor-
matics software Mathminer (http://discover.nci.nih.
Figure 1 Images of gene microarray nylon membranes. (A) Illustration of gene display on the microarray nylon 
membranes. (B) Gene expression in the apoptosis and angiogenesis pathways under various clinical grades of varicose 
veins (VVs): (a) grade 1, overexpression in six genes; (b) grade 2, overexpression in seven genes; (c) grade 3, overex-
pression in nine genes; (d) grade 4, overexpression in 10 genes; (e) grade 5, overexpression in 11 genes; (f) grade 6, 
overexpression in 12 genes.
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gov/matchminer/index.jsp). After the conversion, 
the names were input into the bioinformatics soft-
ware GoMiner for annotations with the concept of 
Gene Ontology. There were 32 upregulated genes 
(VV to CV ratio, ≥ 2) (Table) and 74 downregulated 
genes (VV to CV ratio, ≤ 0.5) (data not shown). We 
then annotated the biological response pathways 
in which the 32 upregulated genes were involved, 
according to the analysis database website provided 
by DAVID, and selected the genes whose pathways 
could be found in the biological response pathways 
databases KEGG and BIOCARTA. The results showed 
three possible significant pathways: hypo xia and 
p53 in the cardiovascular system, hypoxia-inducible 
factor (HIF) in the cardiovascular system, and PTEN-
dependent cell cycle arrest and apoptosis. These 
pathways can be categorized as either apoptosis or 
angiogenesis-related pathways. It has also been 
found that the HSP90, ILK and TGFB1 genes play 
important roles in the correlation of the three path-
ways (http://www.biocarta.com). Accordingly, we 
used Gene Ontology to further explore the genes re-
lated to both apoptosis and angiogenesis pathways. 
In addition, the membrane array platform built in 
our laboratory was used to analyze the gene expres-
sion of 20 VV specimens in the clinic. We character-
ized the genes involved in angiogenesis and apoptosis 
pathways in the present study, including the HSP90, 
ILK and TGFB1 genes, which all had high overexpres-
sion patterns (Figure 1). Moreover, the expression 
levels of these genes were significantly correlated 
with VV characterization of clinical grade.
Discussion
Currently, VVs still affect millions of people. However, 
there has been little investigation of gene expression 
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of VVs. The purpose of this study was to systemati-
cally explore the biological pathways of genes spec-
ulatively participating in VVs by using microarray 
bioinformatics analysis methods. Microarray-based 
analysis is a promising new technology that allows 
the rapid detection of gene expression profiles of 
large numbers of genes simultaneously, and cur-
rently, adequate bioinformatics approaches are de-
veloping at a rapid pace to facilitate information 
management. The combined use of microarray bi-
oinformatics to provide insight into the complex 
networks of molecular pathways underlying the de-
velopment of VVs has not yet been conducted. By 
using a combined oligonucleotide microarray bio-
informatics method, we found 106 differentially ex-
pressed genes and identified two of the significant 
molecular pathways participating in VVs.
The two pathways with significant potential 
for VV diagnosis or preventive medicine are the 
apoptosis and angiogenesis pathways. The first in-
volves hypoxia and p53 in the cardiovascular sys-
tem. When DNA is damaged, downstream products 
that relate to p53 will increase (Figure 2, blue 
box). During hypoxia, the products of p53 will take 
the feedback loop (Figure 2, orange arrows), which 
include genes such as HSP90 that inhibit the activi-
ties of this loop. After p53 combines with MDM2, 
it then combines with ubiquitin and interacts 
with proteasome to form stable p53 and HIF for 
the next reaction (Figure 2). The second is HIF in 
the cardiovascular system. During hypoxia, HIF 
causes the downstream product (Figure 3, purple ir-
regular polygon) to respond to hypoxia to increase 
oxygen concentration in the cells to facilitate 
angiogenesis, erythropoiesis, and glucose metabo-
lism. The last is PTEN-dependent cell cycle arrest 
and apoptosis.The PKB/AKT compound inhibits 
apoptosis, which in turn, stops production of the 
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downstream products of apoptosis. ILK activates 
the PKB/AKT compound, thereby inhibiting apop-
tosis (Figure 4). The three genes, HSP90, ILK 
and TGFB1, have a critical role in the three path-
ways. HSP90 belongs to the IAP family, and its pro-
tein function is to regulate the checkpoint, apoptosis, 
and cell death in mitosis.6−9 The regulation of AKT 
activity by ILK affects apoptosis, and ILK and VEGF 
both play key roles in tumor angiogenesis.10 TGFB1 is 
a multifunctional gene involved in proliferation, dif-
ferentiation, apoptosis, and angiogenesis.11−13
The three genes HSP90, ILK, and TGFB1 have 
been found to be associated with apoptosis and 
angiogenesis, which is similar to the findings in our 
study.14 However, no studies have investigated the 
corre lation between the genes, HSP90, ILK, TGFB1 
and GAPD, and the development of varicose veins. 
The membrane array platform built in our labora-
tory has demonstrated the genes involved in the 
angiogenesis pathway and apoptosis pathway. We 
found that 3 of 32 genes were correlated with 
VV characterization of clinical grade (Figure 1). 
Genetic expression profiles play an important role 
in the development of VVs. The understanding of 
cellular apoptosis and the mechanism of angiogen-
esis could enable the analysis and identification of 
the molecular mechanism that causes VVs. To pre-
vent and treat VVs, these genes could be used to 
identify people who are at high risk for VVs.
In conclusion, this study demonstrates that the 
angiogenesis and apoptosis pathways may play an 
important role in the formation of VVs, but their 
molecular mechanisms need further investigation.
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